Michael Panzara, M.D.Chief Medical Officer at Wave Life Sciences
Michael A. Panzara, MD, MPH is currently Chief Medical Officer, Head of Therapeutics Discovery and Development at Wave Life Sciences Ltd. and oversees Wave’s portfolio of therapeutic research and development programs with a focus on genetically-defined neurodegenerative diseases. Dr. Panzara has 20 years of biopharmaceutical industry experience developing therapies for neurological disorders. Prior to joining Wave in 2016, he served as the Head of the Multiple Sclerosis, Neurology and Ophthalmology Therapeutic Area for Global Development at Sanofi Genzyme and was responsible for development strategy and oversight for compounds within these therapeutic areas. He joined Genzyme in 2009 as Group Vice President, Multiple Sclerosis and Immune Diseases, overseeing the development of MS and other inflammatory disease therapies. Prior to joining Genzyme, Dr. Panzara was Vice President and Chief Medical Officer of Neurology at Biogen where he managed clinical development activities for all late-stage MS products. Dr. Panzara received his undergraduate degree in biology from the University of Pennsylvania and medical degree from Stanford University School of Medicine. He trained in neurology at Massachusetts General Hospital, received his post-doctoral training in immunology and rheumatology at Brigham and Women's Hospital, and received his Master of Public Health degree from the Harvard School of Public Health.